Drug Delivery–mediated Control of RNA Immunostimulation
David N. Nguyen(University of California, San Francisco), Daniel G. Anderson(Massachusetts Institute of Technology), Tatiana I. Novobrantseva(Alnylam Pharmaceuticals (United States)), Antonin de Fougerolles(Alnylam Pharmaceuticals (United States)), Steve C-Y Chen(IIT@MIT), Róbert Langer(Massachusetts Institute of Technology), Jianzhu Chen(Massachusetts Institute of Technology), Jennifer Sherman(Alnylam Pharmaceuticals (United States)), Andrew Sprague(Alnylam Pharmaceuticals (United States)), Michael S. Goldberg(Jefferson Einstein Philadelphia Hospital), Svetlana Shulga‐Morskaya(Alnylam Pharmaceuticals (United States)), Phillip Kim(Prometheus Biosciences (United States)), James Lu(Genesys (United States))
Cited by 30
Related Papers
Transdermal drug delivery
|Nature Biotechnology|2008|3.4k
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|Advanced Drug Delivery Reviews|2016|3.2k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k